Jean‐Marc Navenot

A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma

Donald M. O’Rourke, MacLean P. Nasrallah, Arati Desai et al. · Science Translational Medicine · 2017 · 1.7K citations · Full text

Cell Therapy, Antigen Loss, Immunology +16

Antitumor Activity Associated with Prolonged Persistence of Adoptively Transferred NY-ESO-1 c259T Cells in Synovial Sarcoma

Sandra P. D’Angelo, Luca Melchiori, Melinda S. Merchant et al. · Cancer Discovery · 2018 · 418 citations · Full text

Afamitresgene autoleucel for advanced synovial sarcoma and myxoid round cell liposarcoma (SPEARHEAD-1): an international, open-label, phase 2 trial

Sandra P. D’Angelo, Dejka M. Araujo, Albiruni R. Abdul Razak et al. · The Lancet · 2024 · 215 citations · Full text

Afamitresgene Autoleucel, Advanced Synovial Sarcoma, Medicine +3

Autologous T cell therapy for MAGE-A4+ solid cancers in HLA-A*02+ patients: a phase 1 trial

David S. Hong, Brian A. Van Tine, Swethajit Biswas et al. · Nature Medicine · 2023 · 171 citations · Full text

Long-term safety and activity of NY-ESO-1 SPEAR T cells after autologous stem cell transplant for myeloma

Edward A. Stadtmauer, Thomas Faitg, Daniel E. Lowther et al. · Blood Advances · 2019 · 85 citations · Full text